# Warming Sensation and Tolerability Study of Acetylcysteine 2% Oral Solution for Productive Cough

> **NCT02822287** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 58 (actual)

## Conditions studied

- Common Cold

## Interventions

- **DRUG:** Acetylcystine

## Key facts

- **NCT ID:** NCT02822287
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2017-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02822287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02822287, "Warming Sensation and Tolerability Study of Acetylcysteine 2% Oral Solution for Productive Cough". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02822287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*